Travere Therapeutics, Inc. · NASDAQ:TVTX
Janus Henderson Group PLC reported a 11.90% stake in Travere Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Janus Henderson Group PLC reported a 11.90% stake in Travere Therapeutics, Inc., 10,599,660 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 11.90%
- Shares
- 10,599,660
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 11.90% | 10,599,660 |
Source
Related
- Travere Therapeutics, Inc.
- Janus Henderson Group PLC
- Travere Therapeutics, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Aug 7, 2025
- Schedule 13G · Janus Henderson Group PLC · May 14, 2025
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026